Douglas R. Lowy, acting director of the NCI whose research led to the development of the human papillomavirus vaccine, received a Doctor of Science degree from New York University May 22.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
